{"id":93168,"date":"2023-07-31T16:23:00","date_gmt":"2023-07-31T14:23:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=93168"},"modified":"2023-08-01T09:29:19","modified_gmt":"2023-08-01T07:29:19","slug":"hera-invest","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/93168\/hera-invest\/","title":{"rendered":"HERA Invest: EIB supports healthtech startups with 100 million euros"},"content":{"rendered":"<div class=\"entry-content\">\n<p>HERA Invest was funded by the European Commission and the <a href=\"\/en\/day\/eib\/\">EIB<\/a> was launched as a top-up to the InvestEU program, which is dedicated to promoting research and development in the field of cross-border health threats and is funded by the EU4Health program.<\/p>\n\n\n\n<p>The abbreviation HERA stands for <a href=\"https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera_en\" target=\"_blank\" rel=\"noreferrer noopener\">European Health Emergency Response Authority<\/a>It was created in response to the COVID-19 pandemic as a European authority for public health emergency response. The program is intended to become a key pillar of the authority and contribute to the prevention of and preparedness for health emergencies, including by providing financial support for the development of new medical countermeasures. The program also aims to stimulate private investment by mobilizing public funds.<\/p>\n\n\n\n<p>HERA Invest is aimed at small and medium-sized enterprises and startups that specialize in one of the following three health risks:<\/p>\n\n\n\n<ul><li>Pathogens with epidemic or pandemic potential<\/li><li>Antimicrobial resistance<\/li><li>Chemical, biological, radiological and nuclear threats from accidental or deliberate release<\/li><\/ul>\n\n\n\n<p>In addition, the companies must have already received capital from professional investors. They are also required to have a viable business model, a business plan, and sound corporate management. They will receive support from <a href=\"https:\/\/www.eib.org\/en\/products\/equity\/venture-debt\/index\" target=\"_blank\" rel=\"noreferrer noopener\">Venture Loans<\/a>, which cover up to 50 percent of the total project costs. Applications for HERA Invest are accepted on an ongoing basis; there are no deadlines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">With HERA Invest against the weaknesses of the healthcare system<\/h2>\n\n\n\n<p><strong>Stella Kyriakides<\/strong>, EU Commissioner for Health and Food Safety, explains:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;Through HERA Invest, we are investing \u20ac100 million in research and development to develop new and innovative medical countermeasures, thus improving our preparedness for future health threats. Together with the European Investment Bank, HERA Invest will attract additional private and public investment and provide European companies with the security they need to invest in groundbreaking innovations to address the greatest health threats. Here we see a clear example of a strong European Health Union taking action to better protect the health of our citizens.&quot;<\/p><\/blockquote>\n\n\n\n<p><strong>Thomas \u00d6stros<\/strong>, EIB Vice-President responsible for Health and Life Sciences, added:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;COVID-19 has painfully shown us the need to address the weaknesses of our healthcare systems. HERA Invest will help us do just that. Through HERA Invest, we will support companies developing promising new ways to protect us from unpredictable health threats like pandemics or from known challenges like antibiotic resistance. This support is vital to keep Europe at the forefront of innovation and could save millions of lives around the planet if a new health emergency arises.&quot;<\/p><\/blockquote>\n\n\n\n<p>Further information on applying for HERA Invest can be found on the <a href=\"https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/hera-invest_en\" target=\"_blank\" rel=\"noreferrer noopener\">EIB website<\/a>.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The European Investment Bank (EIB) has launched HERA Invest, a new investment program. The \u20ac100 million instrument will be used to promote research and development in the healthtech sector.<\/p>","protected":false},"author":33,"featured_media":93170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[2969,4127,4321],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die EIB hat mit HERA Invest ein neues Investitionsprogramm zur F\u00f6rderung von Forschung und Entwicklung im Healthtech-Bereich gestartet.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/93168\/hera-invest\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die EIB hat mit HERA Invest ein neues Investitionsprogramm zur F\u00f6rderung von Forschung und Entwicklung im Healthtech-Bereich gestartet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/93168\/hera-invest\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-31T14:23:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-01T07:29:19+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/\",\"url\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/\",\"name\":\"HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg\",\"datePublished\":\"2023-07-31T14:23:00+00:00\",\"dateModified\":\"2023-08-01T07:29:19+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Die EIB hat mit HERA Invest ein neues Investitionsprogramm zur F\u00f6rderung von Forschung und Entwicklung im Healthtech-Bereich gestartet.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg\",\"width\":2400,\"height\":1350,\"caption\":\"HERA Invest\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HERA Invest: EIB supports healthtech startups with 100 million euros - Munich Startup","description":"The EIB has launched HERA Invest, a new investment program to promote research and development in the healthtech sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/93168\/hera-invest\/","og_locale":"en_US","og_type":"article","og_title":"HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro - Munich Startup","og_description":"Die EIB hat mit HERA Invest ein neues Investitionsprogramm zur F\u00f6rderung von Forschung und Entwicklung im Healthtech-Bereich gestartet.","og_url":"https:\/\/cms.munich-startup.net\/en\/93168\/hera-invest\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-07-31T14:23:00+00:00","article_modified_time":"2023-08-01T07:29:19+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/","url":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/","name":"HERA Invest: EIB supports healthtech startups with 100 million euros - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg","datePublished":"2023-07-31T14:23:00+00:00","dateModified":"2023-08-01T07:29:19+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"The EIB has launched HERA Invest, a new investment program to promote research and development in the healthtech sector.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/93168\/hera-invest\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg","width":2400,"height":1350,"caption":"HERA Invest"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/93168\/hera-invest\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"HERA Invest: EIB f\u00f6rdert Healthtech-Startups mit 100 Millionen Euro"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":2400,"height":1350,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/07\/scientist-modern-equipped-medical-laboratory-examinining-drug-discovery-with-micropipette-medical-stuff-examining-vaccine-evolution-using-high-tech-technology-researching-treatment-developmen.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1690874960:42","_edit_last":"42","_yoast_wpseo_focuskw":"HERA Invest","_yoast_wpseo_metadesc":"Die EIB hat mit HERA Invest ein neues Investitionsprogramm zur F\u00f6rderung von Forschung und Entwicklung im Healthtech-Bereich gestartet.","_yoast_wpseo_linkdex":"78","_thumbnail_id":"93170","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"1","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93168"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=93168"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93168\/revisions"}],"predecessor-version":[{"id":93195,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93168\/revisions\/93195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/93170"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=93168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=93168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=93168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}